⌘K
Loading ticker…
As of 2026-08-24, Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares (KNSA) has a 3-month relative strength percentile of 94 and a leadership percentile of 97 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 73. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 4.6%, relative volume 0.60×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
KNSA is in a stage 2 uptrend, week 11. Currently in a 18-day base; basing ADR 3.6% (broad 4.2%). VCP detected: no. RS line below base-start high. Distance from 50d / 200d: 17.5% / 55.3%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
KNSA is held by 6 ETFs as of May 2026. Top owner: VHT at 0.03% weight, $5M notional. Top 3 carry $9M.
Held by 19 ETFs · $161M across latest filings · largest weight 2.06% (BBP).
Top 6 by value, from SEC N-PORT-P filings dated May 2026.
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY diluted average shares. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.05% |
| $4K |
| — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | KNSA Jan avg: 0.65% median: -0.20% win: 50% σ: 4.22% n: 4 2022-04-12 → 2026-07-31 | KNSA Feb avg: 3.40% median: 2.38% win: 75% σ: 12.73% n: 4 2022-04-12 → 2026-07-31 | KNSA Mar avg: -1.31% median: 0.78% win: 50% σ: 12.42% n: 4 2022-04-12 → 2026-07-31 | KNSA Apr avg: 2.83% median: -0.09% win: 40% σ: 13.89% n: 5 2022-04-12 → 2026-07-31 | KNSA May avg: 0.80% median: 1.45% win: 60% σ: 17.75% n: 5 2022-04-12 → 2026-07-31 | KNSA Jun avg: 11.92% median: 1.59% win: 80% σ: 16.08% n: 5 2022-04-12 → 2026-07-31 | KNSA Jul avg: 20.83% median: 16.25% win: 100% σ: 16.84% n: 5 2022-04-12 → 2026-07-31 | KNSA Aug avg: 5.23% median: 5.60% win: 75% σ: 11.71% n: 4 2022-04-12 → 2026-07-31 (current) | KNSA Sep avg: 4.94% median: 5.18% win: 75% σ: 9.86% n: 4 2022-04-12 → 2026-07-31 | KNSA Oct avg: -9.39% median: -10.33% win: 0% σ: 3.31% n: 4 2022-04-12 → 2026-07-31 | KNSA Nov avg: 16.51% median: 10.46% win: 75% σ: 21.73% n: 4 2022-04-12 → 2026-07-31 | KNSA Dec avg: -3.98% median: -6.70% win: 25% σ: 9.07% n: 4 2022-04-12 → 2026-07-31 |